Clinical trials
Anemia, Refractory, with Excess of Blasts trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 6 |
| Terminated | 5 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| University of California, San Francisco | 2 |
| University of Washington | 2 |
| Advice Pharma Group srl | 1 |
| Asan Medical Center | 1 |
| Case Comprehensive Cancer Center | 1 |
| Children's Hospital of Philadelphia | 1 |
| European Institute of Oncology | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Fujian Medical University Union Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 22 |
| Leukemia, Myeloid, Acute | 17 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia | 10 |
| Hodgkin Disease | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Multiple Myeloma | 8 |
| Burkitt Lymphoma | 7 |
| Congenital Abnormalities | 7 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.